The company's research efforts are focused on vaccines and diagnostics
for both veterinary and human infectious diseases and cancers. The
company has three preventive and therapeutic DNA vaccines in research
and development to combat Hepatitis B and C, Mycobacterium
tuberculosis and Bovine Viral Diarrhea Virus infections. Our Bovine
Viral Diarrhea Virus, Hepatitis and Mycobacterium tuberculosis DNA
vaccines and Diagnostics are in clinical evaluation and the results have
been publishing in the International Journals. JN has promised to
emphasize global health needs within these Research Programs along
with the Microbiology Education. The fact that we work at the fore
front of discovery inspires us to continue developing innovative tools
that will help our advance the life science. Our research and development
have been supported by our investors, profit and non-profit
organizations.

JN is committed to maintaining research and development excellence in
vaccine and diagnostics with the launch of its new program in medical
research. With strength of our support of JN's mission and values, we
are seeking the best, most diverse scientists to head the race into the
future of newer diagnostics, preventive vaccine and therapies. Presently,
we are either contact out or out source some of the products to cGMP,
MCA and MCC manufacturers to meet the regulatory requirements for
large overseas tender supplies.

Click here to request information

---